Nano Pharmaceuticals
Market Cap
₹44 ₹44.00 Cr.
P/E
18.91
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.11
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
12.79 %
Institutions
Institutions
-
Market cap
Market cap
44.00 Cr
No. of Shareholders
No. of Shareholders
393
OPM (%)
OPM (%)
9.15 %
PE
PE
18.91
Prom Holding
Prom Holding
73.44 %
ROCE (%)
ROCE (%)
18.50
ROE (%)
ROE (%)
13.87
Sales
Sales
42.03 Cr
  • Amkay Products
  • KMS Medisurgi
  • GKB Ophthalmics
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      39
      52W Range
      High
      82
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      8 Yes

      Positive for this company

      2 Neutral

      Neutral for this company

      5 No

      Negative for this company

      2 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Peer Comparison

      FAQs on Amkay Products Ltd. Business

      Amkay Products was incorporated on October 25, 2007. It manufactures, assembles &amp; markets a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India. In addition, it is also engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.

      Amkay Products major competitors are KMS Medisurgi, Shree Pacetronix, Centenial Surg. Sut., GKB Ophthalmics, Kretto Syscon, Galaxy Medicare, Boston Commerce.
      Market Cap of Amkay Products is ₹44 Crs.
      While the median market cap of its peers are ₹32 Crs.

      Amkay Products seems to be less financially stable compared to its competitors.
      Altman Z score of Amkay Products is 6.53 and is ranked 4 out of its 8 competitors.

      Company Filing

      2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
      Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
      Earnings Release
      Investor Presentation
      Conference Call
      Conference Call SummaryCon Call Summary

      Discussions & Analysis

      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material